Opinion on the Optimal Histologic Evaluation of the Bone Marrow in Nonclinical Toxicity Studies

• Published in: Toxicologic pathology Vol. 50; no. 2; pp. 266 - 273
• Main Author: Biddle, Kathleen E.
• Format: Journal Article
• Language: English
• Published: Los Angeles, CA SAGE Publications 01-02-2022
• Subjects: histology; bone marrow; nonclinical toxicity studies
• ISSN: 0192-6233; 1533-1601
• DOI: 10.1177/01926233211061712

Identification of bone marrow toxicity is an important issue in drug development and toxicologic pathologists play a critical role in that identification. Knowledge of the general components of bone marrow, relevant anatomical and species differences, and the standard approach (routine systematic histological evaluation of the bone marrow in conjunction with analysis of the peripheral complete blood count data) will be reviewed. Specific morphologic features that anatomic pathologists should look for in the various components of bone marrow as well as suggested terminology for bone marrow findings will be discussed. Finally, an opinion on the limitations of the standard approach to bone marrow evaluation will be provided including general recommendations on when additional methods (image analysis of hematoxylin and eosin stained slides, flow cytometry or Sysmex XT 2000iV analysis, cytological evaluation of bone marrow smears, in vitro models, and transmission electron microscopy) might be useful in the detection or further characterization of bone marrow toxicity.
This is an opinion article submitted to the Toxicologic Pathology Forum. It represents the views of the author. It does not constitute an official position of the Society of Toxicologic Pathology, British Society of Toxicological Pathology, or European Society of Toxicologic Pathology, and the views expressed might not reflect the best practices recommended by these Societies. This article should not be construed to represent the policies, positions, or opinions of their respective organizations, employers, or regulatory agencies.